Rimonabant Improves Glycemic Control in Insulin-Treated Type 2 Diabetes - ARPEGGIO

Description:

The goal of this trial was to evaluate the safety and efficacy of rimonabant on glycemic control in patients with type 2 diabetes and cardiovascular disease, and who are not adequately controlled with insulin.